Quantcast
Last updated on April 17, 2014 at 7:54 EDT

Latest Dermal fibroblast Stories

Stem Cell Treatment For Baldness
2014-01-28 10:40:14

[ Watch the Video: Bald Men May One Day Get Help From Stem Cells ] Brett Smith for redOrbit.com - Your Universe Online While a Chinese cream may not have cured George Costanza’s baldness in a classic Seinfeld episode, stem cell research from scientists at the University of Pennsylvania has shown the potential for regenerating hair follicles – which could lead to relief for hair-challenged men everywhere. According to a new report published in the journal Nature Communications,...

2013-08-22 08:26:27

Proprietary Dermal Fibroblast-Based Product in HypoThermosol Could Greatly Improve Treatment of a Debilitating Skin Condition and also Burn Injuries BOTHELL, Wash., Aug. 22, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced that its HypoThermosol, a pre-formulated,...

2013-08-01 16:30:16

MARIETTA, Ga., Aug. 1, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its study "Biological Properties of Dehydrated Human Amnion/Chorion Grafts: Implications for Chronic Wound Healing" has been electronically published in the International Wound Journal. The electronic publication of the study is...

2013-01-08 08:29:45

LEXINGTON, Massachusetts, January 8, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), announces that it has signed an agreement to acquire Lotus Tissue Repair, Inc. of Cambridge, MA, a privately held biotechnology company developing the first and only protein replacement therapy currently being investigated for the treatment of dystrophic epidermolysis bullosa (DEB). DEB is a devastating orphan disease for which there is no currently approved treatment option other than...

2012-11-28 08:29:31

FORT WORTH, Texas, Nov. 28, 2012 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announced today that it has signed an agreement to acquire substantially all of the assets of Healthpoint Biotherapeutics for $782 million in cash. The transaction is subject to regulatory approval and is expected to close in December 2012. Healthpoint Biotherapeutics, founded in 1992 by Chairman and CEO Paul Dorman, has been focused on biopharmaceutical...

2012-09-27 06:28:36

CINCINNATI, Sept. 27, 2012 /PRNewswire-USNewswire/ -- Researchers have discovered a previously unknown function for a protein that could add to the expanding arsenal of potential new drugs for battling inflammation and tissue fibrosis in a number of disease processes. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Scientists from Cincinnati Children's Hospital Medical Center report Sept. 27 in Developmental Cell that, a protein called TRPC6 mediates a molecular pathway...